ISA Pharmaceuticals BV: ISA Pharmaceuticals B.V. is an immunotherapy company developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections. The Company has built a proprietary immunotherapy platform based on the Synthetic Long Peptide (SLP®) concept and AMPLIVANT®technology. SLP®immunotherapies are designed to fully harness and direct the body’s own defenses towards fighting the disease.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase III, Phase l or ll
Disease Space
Anti-infectives, Antivirals, Infectious Disease, Oncology
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Private
Market Cap
100MM - 500MM
Therapeutic Modalities
Antibodies, Cell Therapy
Website:
Profiles:
Address:
J.H. Oortweg 19-21
Leiden, 2333 CH
Netherlands

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Fall Private Company Showcase 2020

VIRTUAL, October 15, 2020